To reveal the role of p53 and OPG in cancer associated bone remodeling, we use Synergy2G (www.bioprofiling.de/synergy2g) to explore their correlation in prostate cancer patients [40, 41]. The gene discussed is TP53; the disease is prostate carcinoma.